LifeMD Investors Can Lead a Potential Securities Fraud Class Action Lawsuit

Potential Class Action Opportunity for LifeMD Investors

Investors who purchased shares of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025, and August 5, 2025, are being encouraged to take part in a potential class action lawsuit filed by The Rosen Law Firm. The firm is recognized globally for its dedication to investor rights and is now focusing on this class action amid allegations of securities fraud.

Case Background

The Rosen Law Firm has brought attention to critical deadlines in this case, specifically the October 27, 2025, lead plaintiff deadline. This timeline is crucial for investors who believe they may have been impacted by misleading information regarding LifeMD's prospects and financial position. Eligible investors have the opportunity to recover damages without incurring out-of-pocket expenses, as the firm operates on a contingency fee basis.

The allegations center around claims that LifeMD made materially false and misleading statements regarding its business operations and competitive standing. During the class period, it is asserted that the company’s management overstated its potential and did not adequately disclose significant costs associated with customer acquisition in its RexMD segment. This also includes costs related to new medications intended for obesity treatment, which were not properly factored into the publicly shared guidance for 2025.

How to Participate

To get involved in this class action lawsuit against LifeMD, investors can go to Rosen Law Firm's submission form or reach out via phone at 866-767-3653. Those interested in becoming a lead plaintiff must act swiftly, as a motion must be filed with the court no later than the aforementioned deadline. A lead plaintiff acts on behalf of the entire class, guiding the litigation process.

The Rosen Law Firm advocates for investors to choose legal representation that demonstrates a strong history of success in securities cases. They caution against firms that may lack the experience necessary to effectively litigate class actions, suggesting that many merely act as intermediaries.

Noteworthy Accomplishments

The Rosen Law Firm has established a significant reputation in the field of securities class action litigation. They previously secured the largest settlement against a Chinese company at that time and consistently rank among the top firms for settlements. In 2019, they recovered over $438 million for investors, showcasing their capability and experience.

Moving Forward

As this case proceeds, investors are advised to keep abreast of any updates related to the class action and their rights as potential claimants. Keep in mind that until the class is certified, individuals are not represented unless they retain legal counsel.

Investors can remain passive if they choose, but participation as a lead plaintiff may enhance their chances of receiving compensation should the lawsuit succeed. For ongoing updates on this case and to follow developments in similar lawsuits, investors are encouraged to connect with The Rosen Law Firm on LinkedIn, Twitter, and Facebook.

In conclusion, this class action lawsuit represents a significant opportunity for investors who may have been misled during the class period. Ensuring timely action and proper legal advice will be essential in navigating this critical situation.